Atlas Trials

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Clinical trial NCT06947707 · RECRUITING

Trial details

NCT number
NCT06947707
Sponsor
Xuanwu Hospital, Beijing
Status
RECRUITING
Study type
OBSERVATIONAL
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation TreatmentAnticoagulant TherapyAnticoagulant DrugsNOACsAnticoagulant Prophylaxis/TherapyAnticoagulation With NOACAnticoagulation With Direct Oral Anticoagulants
Start date
2025-04-10
Primary completion
2027-12-31
Enrollment
1486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.